نتایج جستجو برای: cT3a Prostate Cancer

تعداد نتایج: 933100  

Hsu ChY, Joniau S Oyen R Roskams T VanPoppel H

Background: According to the EAU guidelines, a life expectancy of more than 10 years is considered an important factor in the treatment of prostate cancer. The Charlson score is used to predict mortality based on comorbidies.The purpose of this study was to investigate the relationship between age, Charlson score and outcome in patients with cT3a prostate cancer. Materials and Methods: Between ...

Azodi P Jahanpour F, Jahanpour NS

Background: According to the EAU guidelines, a life expectancy of more than 10 years is considered an important factor in the treatment of prostate cancer. The Charlson score is used to predict mortality based on comorbidies.The purpose of this study was to investigate the relationship between age, Charlson score and outcome in patients with cT3a prostate cancer. Materials and Methods: Between ...

Journal: :European urology 2015
Steven Joniau Martin Spahn Alberto Briganti Giorgio Gandaglia Bertrand Tombal Lorenzo Tosco Giansilvio Marchioro Chao-Yu Hsu Jochen Walz Burkhard Kneitz Pia Bader Detlef Frohneberg Alessandro Tizzani Markus Graefen Paul van Cangh R Jeffrey Karnes Francesco Montorsi Hein van Poppel Paolo Gontero

BACKGROUND Pretreatment tables for the prediction of pathologic stage have been published and validated for localized prostate cancer (PCa). No such tables are available for locally advanced (cT3a) PCa. OBJECTIVE To construct tables predicting pathologic outcome after radical prostatectomy (RP) for patients with cT3a PCa with the aim to help guide treatment decisions in clinical practice. D...

2009
Chao-Yu Hsu Steven Joniau Raymond Oyen Tania Roskams Hein Van Poppel

Introduction: A higher body mass index (BMI) has been correlated with worse outcome after radical prostatectomy (RP), but this observation has been mainly noticed in clinically localized disease. The objective of this study is to analyze the relationship between BMI and outcome of surgery for clinical unilateral T3a (cT3a) prostate cancer. Patients and Methods: Two hundred patients with cT3a pr...

Journal: :Medical oncology 2014
Kazuhiro Matsumoto Masayuki Hagiwara Nobuyuki Tanaka Nozomi Hayakawa Masaru Ishida Akiharu Ninomiya Yosuke Nakajima So Nakamura

The representative guidelines do not recommend androgen deprivation therapy (ADT) as a primary treatment for localized prostate cancer. However, in clinical practice, the use of primary ADT for localized prostate cancer has been widespread, especially among older patients. We performed a retrospective review of the efficacy of primary ADT for localized prostate cancer and compared their outcome...

2008
Michel Soulié

Among the optimal options recommended for locally advanced prostate cancer, radical prostatectomy (RP) with or without adjuvant radiotherapy or hormone therapy is a possible but relatively infrequent option. The role of radical prostatectomy in locally advanced prostate cancer is still controversial and has not been extensively assessed despite numerous recent series provided by great US and Eu...

2015
Lucas Regis Ana Celma Jacques Planas Ines deTorres Roser Ferrer Juan Morote

Background: Circulating testosterone remains the main source of androgens, however only 1%-2% circulates as free testosterone (fT), hormone active form. To compare the performance of serum fT and total testosterone (tT) as predictors of prostate cancer (PCa) detection and aggressiveness. Methods: Serum fT (RIA, pg/mL) and tT (LC/MS, ng/dL) were prospectively determined in 3364 consecutive men w...

Journal: :Asian journal of andrology 2009
Chao-Yu Hsu Steven Joniau Raymond Oyen Tania Roskams Hein Van Poppel

According to the European Association of Urology (EAU) guidelines, a life expectancy of > 10 years is considered an important factor in the treatment of prostate cancer. The Charlson score is used to predict mortality based on comorbidities. The purpose of this study was to investigate the relationship between age, Charlson score and outcome in patients with cT3a prostate cancer. Between 1987 a...

2014
Alfonso Gomez-Iturriaga Juanita Crook Francisco Casquero Claudia Carvajal Arantxa Urresola Begoña Canteli Ana Ezquerro Eduardo Hortelano Jon Cacicedo Jose Maria Espinosa Fernando Perez Pablo Minguez Pedro Bilbao

PURPOSE The purpose of this study was to evaluate the impact of intraoperative MRI/TRUS fusion procedure in cT3a prostate cancer patients treated with high-dose-rate (HDR) real-time brachytherapy. MATERIAL AND METHODS Prostate gland, dominant intraprostatic lesions (DILs), and extracapsular extension (ECE) were delineated in the pre-brachytherapy magnetic resonance images (MRI) of 9 consecuti...

Journal: :international journal of hematology-oncology and stem cell research 0
mozaffar aznab imam reza hospital and taleghani hospital, kermanshah university of medical sciences, kermanshah, iran bahram samadzadeh imam reza hospital, kermanshah university of medical sciences, kermanshah, iran assad moradi imam reza hospital, kermanshah university of medical sciences, kermanshah, iran abdol rosol bardideh imam reza hospital, kermanshah university of medical sciences, kermanshah, iran jamal hoseini clinical research developemental center, kermanshah university of medical sciences, kermanshah, iran kazhal kaviani moghadam statistic department, private statistic institute, kermanshah, iran

introduction: prostate cancer is one of the most common cancers among males and the second factor resulting to death due to cancer among them.(1) the median age of its diagnosis is 65 years. the initial treatment includes androgen ablation or orchiectomy.(2, 3) in case of patient’s hormone refractory, chemotherapy would be substituted. the objective of this study is the consideration of intermi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید